FDA Inspection 1300420 — Akron General Medical Center Institutional Research Review Board
The FDA completed an inspection of Akron General Medical Center Institutional Research Review Board on Jan 22, 2026 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Akron, OH (United States)
Additional Details
IRB